Further studies are needed to confirm the beneficial effect of fish oil on the FGF21 resistance in NAFLD, and to investigate the underlying mechanisms for FGF21 as a therapy target of NAFLD and other diseases treatment. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.